Study to investigate HDP-101

Trial Profile

Study to investigate HDP-101

Planning
Phase of Trial: Phase I

Latest Information Update: 12 Apr 2017

At a glance

  • Drugs HDP 101 (Primary)
  • Indications Multiple myeloma
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Apr 2017 According to a Wilex AG media release, company plans to initiate this study in late 2018.
    • 30 Jan 2017 New trial record
    • 25 Jan 2017 According to a Wilex AG media release, company plans to initiate this study in 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top